445 related articles for article (PubMed ID: 9988278)
1. Direct activation of TERT transcription by c-MYC.
Wu KJ; Grandori C; Amacker M; Simon-Vermot N; Polack A; Lingner J; Dalla-Favera R
Nat Genet; 1999 Feb; 21(2):220-4. PubMed ID: 9988278
[TBL] [Abstract][Full Text] [Related]
2. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
Greenberg RA; O'Hagan RC; Deng H; Xiao Q; Hann SR; Adams RR; Lichtsteiner S; Chin L; Morin GB; DePinho RA
Oncogene; 1999 Feb; 18(5):1219-26. PubMed ID: 10022128
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
[TBL] [Abstract][Full Text] [Related]
4. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of myc and telomerase interactions in vivo.
Flores I; Evan G; Blasco MA
Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
[TBL] [Abstract][Full Text] [Related]
7. Telomerase and c-myc expression in hepatocellular carcinomas.
Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
9. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.
Shkreli M; Dambrine G; Soubieux D; Kut E; Rasschaert D
J Virol; 2007 May; 81(9):4848-57. PubMed ID: 17314164
[TBL] [Abstract][Full Text] [Related]
11. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
[TBL] [Abstract][Full Text] [Related]
12. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
[TBL] [Abstract][Full Text] [Related]
14. Ets2 transcription factor, telomerase activity and breast cancer.
Dwyer JM; Liu JP
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):83-7. PubMed ID: 19566835
[TBL] [Abstract][Full Text] [Related]
15. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Packham G; Cleveland JL
Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
[TBL] [Abstract][Full Text] [Related]
16. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ
J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515
[TBL] [Abstract][Full Text] [Related]
17. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
Oh S; Song YH; Kim UJ; Yim J; Kim TK
Biochem Biophys Res Commun; 1999 Sep; 263(2):361-5. PubMed ID: 10491298
[TBL] [Abstract][Full Text] [Related]
20. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
Günes C; Lichtsteiner S; Vasserot AP; Englert C
Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]